Disruptive Tech Research
  • About
  • Media
  • Research
  • Subscribe
  • Log in
Select Page
[New Pick] It’s Time To Go “All-In” On Another Low-Risk, High-Reward Biotech

[New Pick] It’s Time To Go “All-In” On Another Low-Risk, High-Reward Biotech

by Lou Basenese | Apr 8, 2021 | Trade Alerts

To invest in biotech is to invest in the future. And with this unique, under-the-radar company, we can do so with dramatically reduced risk

[New Pick] Preparing For Second-Order Covid-19 Profits

[New Pick] Preparing For Second-Order Covid-19 Profits

by Lou Basenese | Jan 11, 2021 | Trade Alerts

With micro-caps surging and the Covid-19 pandemic underscoring the vital need for new drugs and therapies, this micro-cap is perfectly positioned to capitalize on the momentum in both areas of the market.

[New Pick] We’re Finally Ready For “The Next Big Thing” In Tech

[New Pick] We’re Finally Ready For “The Next Big Thing” In Tech

by Lou Basenese | Sep 9, 2020 | Trade Alerts, VUZI

Every major tech company is working on augmented reality. This micro-cap pioneer owns all the key patents and is already ramping up sales, making it an obvious takeover target

[New Pick] From Busted To Breakout IPO

[New Pick] From Busted To Breakout IPO

by Lou Basenese | Aug 25, 2020 | Trade Alerts

Artificial intelligence and biotech are the two hottest trends to invest in right now and we’ve found a single micro-cap positioned to profit from both…

[New Recommendation] Introducing Biotech’s Next Multi-Billion $ Platform

[New Recommendation] Introducing Biotech’s Next Multi-Billion $ Platform

by Lou Basenese | Jul 13, 2020 | Trade Alerts

Biotech is THE sector to invest in right now and we’ve found the next micro-cap with multi-billion-dollar platform potential…

Trade Alert: In The Event Of Another Biotech Freeze

Trade Alert: In The Event Of Another Biotech Freeze

by Lou Basenese | Oct 2, 2019 | Trade Alerts

The biotech sector is either “risk on” or “risk off.” Based on history, there could be much more downside ahead. Here’s how to profit from it…

« Older Entries

Your account

Sign in

Research Links

  • Real-Time Blog
  • Active Recs
  • Archive

Recent Posts

  • Q2 2022 Portfolio Review & Outlook
  • ATOM: Lands Another “Major” Foundry Customer, Plus 10 Takeaways From Q1 Report
  • [IMNM] Biotech Absurdity
  • [Video] Cue Biopharma Q&A Session With Dr. D.J. Verret
  • [Video] ATOM: 5 Key Takeaways From The Q4 2021 Report
  • RESN: Time To Lock In Our 5G Gains
  • [CUE] “That Data Is Amazing!” So Why Is The Stock Down?